Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Income Statement Information

The following table provides selected income statement information for our single reportable segment (in thousands):

	December 31, 2024			December 31, 2023			December 31, 2022
Net loss before noncontrolling interest	$	(163,335	)	$	(135,447	)	$	(148,135	)
Rental income		76			–			–
Depreciation and amortization		4,337			2,956			2,448
Equity-based compensation		29,372			30,846			74,469
Income tax (benefit) expense		(598	)		5,996			896
Interest expense		9			12			215
Interest income		19,752			22,083			5,983

Schedule of Significant Expense Reported to the Chief Operating Decision Maker

The following table provides significant expense categories that are regularly reported to the chief operating decision maker (in thousands):

	December 31, 2024			December 31, 2023			December 31, 2022
Revenue	$	76		$	–		$	–
Clinical expense		50,235			42,513			24,963
Cash compensation		48,025			31,374			16,409
Cash operating expenses		45,459			49,431			49,360
Other segment items (1)		19,692			12,129			57,403
Net loss before noncontrolling interest	$	(163,335	)	$	(135,447	)	$	(148,135	)